Insider Sale by Thornberry Nancy (Dir)
Trade Summary
1 week ago, Thornberry Nancy, serving as Dir at Denali Therapeutics Inc. (DNLI), sold 11,439 shares at $22.90 per share, for a total transaction value of $261,928.50. Following this transaction, Thornberry Nancy now holds 19,686 shares of DNLI.
This sale represents a 36.75% decrease in Thornberry Nancy's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 5:02 PM ET, 2 days after the trade was made.
Denali Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$22.90
Quantity
11,439
Total Value
$261,928.50
Shares Owned
19,686
Trade Date
8 days ago
SEC Filing Date
at 5:02 PM ET
Filed 2 days after trade
Discussion